Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2003
05/15/2003US20030092000 Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
05/15/2003US20030091999 Nucleotide sequences coding complex for use in treatment of cancer and viral disease
05/15/2003US20030091997 Chemical inhibitors of mismatch repair
05/15/2003US20030091996 Apoptin-associating protein
05/15/2003US20030091995 Generation of human antibody display library; obtain trangenic animal, transform with nucleotide sequence which code antibodies, form library of display packages displaying antibody chains
05/15/2003US20030091994 Diagnosis via detection hybridization pattern of chromosomal probes; biopsies
05/15/2003US20030091992 Nutrients broth for use in the cytological and molecular analysis
05/15/2003US20030091991 Gene detecting method and test kit
05/15/2003US20030091989 Solating nucleic acids from a sample containing cells or viruses; provide dry solid support, incubate with sample, lyse cell or virus, wash, elute and recover nucleotide sequences
05/15/2003US20030091986 Identification of expressed genes using phage display
05/15/2003US20030091985 Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and use of these DNA clones and polypeptides in diagnostic kits
05/15/2003US20030091984 Methods for judging resistance to the onset of bovine leukemia
05/15/2003US20030091981 Kit for use in the deetction of genes associated with xylogenesis
05/15/2003US20030091977 Assessment method
05/15/2003US20030091597 Genetic engineering; screening for tuberculosis
05/15/2003US20030091594 CD4-independent HIV envelope proteins as vaccines and therapeutics
05/15/2003US20030091592 Inducting immunology response
05/15/2003US20030091591 Parasiticides; veterinary medicine
05/15/2003US20030091590 Recombinant rhabdoviruses as live-viral vaccines
05/15/2003US20030091583 Use of mia in immunotheraphy
05/15/2003US20030091576 Therapy, prevention vascular system diseases; administering fusion protein; cardiovascular disorders
05/15/2003US20030091575 Activation immunology response; administering fusion protein
05/15/2003US20030091573 Methods and compositions for the diagnosis and treatment of hematological disorders using 16319
05/15/2003US20030091572 Methods and compositions for the treatment and diagnosis of pain disorders using 2047
05/15/2003US20030091571 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777
05/15/2003US20030091570 Analgesics; antiinflammatory agents; analyzing drug as to ability to modulation gene expression
05/15/2003US20030091569 Methods for the treatment of carcinoma
05/15/2003US20030091568 Inhibitors for the formation of soluble human CD23
05/15/2003US20030091567 Antiinflammatory agents; anticancer agents
05/15/2003US20030091566 Antitumor agents
05/15/2003US20030091564 Methods of treating an undesired immune response by blocking the binding 0f cd40 ligand to cd40
05/15/2003US20030091562 Nucleic acid and corresponding protein entitled 101P3A41 useful in treatment and detection of cancer
05/15/2003US20030091561 Anticancer agents
05/15/2003US20030091550 Novel strains of bacillus thuringiensis and pesticidal composition comprising them
05/15/2003US20030091546 Surgery removal of cell; transformation, transcription; reinsertion
05/15/2003US20030091544 Gene expression
05/15/2003US20030091539 Use of DF3/MUC1 regulated expression in gene therapy
05/15/2003US20030091538 Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof
05/15/2003US20030091537 Anticancer agents; gene coding immunomoderator cytokine protein
05/15/2003US20030091535 Mutant virus with defective genome; genetic engineering
05/15/2003US20030091534 Adenoviral vectors having a protein IX deletion
05/15/2003US20030091476 Comprises microscopic vessels; for microarrays of DNA and RNA oligonucleotides, peptides, oligosacchrides, and phospholipids; genetic mapping; drug screening
05/15/2003CA2789407A1 Inhibitor oligonucleotides and their use for specific repression of a gene
05/15/2003CA2782864A1 Compositions from the grasses lolium perenne and festuca arundinacea
05/15/2003CA2736469A1 Compositions, methods and kits for determining the presence of mycoplasma pneumoniae and/or mycoplasma genitalium in a test sample
05/15/2003CA2505129A1 Pharmaceutical compositions of marine sponge microciona prolifera
05/15/2003CA2472097A1 Antisense modulation of purinoreceptor p2x3
05/15/2003CA2472055A1 Improved mucosal vaccines and methods for using the same
05/15/2003CA2467853A1 Antibody stimulating il-1ra production
05/15/2003CA2466595A1 Protein knobs
05/15/2003CA2466492A1 Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases
05/15/2003CA2466412A1 Protein kinase stress-related polypeptides and methods of use in plants
05/15/2003CA2466391A1 Polyamide modulators of cox2 transcription
05/15/2003CA2466334A1 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and for enhancing survival of neurons and uses thereof
05/15/2003CA2466333A1 Method of proliferation in neurogenic regions
05/15/2003CA2466203A1 Cross-species somatic cell nuclear transfer using rabbit oocyte
05/15/2003CA2466198A1 Somatic cell derived embryonic stem cells and their differentiated progenies
05/15/2003CA2466138A1 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies
05/15/2003CA2466128A1 Antibodies to cd40
05/15/2003CA2466088A1 Method for selecting genetically transformed cells
05/15/2003CA2465961A1 Isolation and purification of nucleic acids
05/15/2003CA2465953A1 Novel isoforms of vascular endothelial cell growth inhibitor
05/15/2003CA2465951A1 Transcription factor stress-related polypeptides and methods of use in plants
05/15/2003CA2465921A1 Novel compositions and methods for cancer
05/15/2003CA2465886A1 Methods of promoting uptake and nuclear accumulation of polyamides in eukaryotic cells
05/15/2003CA2465849A1 Methods of storing and/or delivering an oligomer and/or polymer applied on a support, and supports thereof
05/15/2003CA2465839A1 Polynucleotides and polypeptides involved in clavulinic acid biosynthesis and use thereof
05/15/2003CA2465828A1 Non-sporulating bacillus subtilis having parts of the gene encoding sigma g deleted
05/15/2003CA2465798A1 Method in the form of a dry rapid test for detecting nucleic acids
05/15/2003CA2465763A1 Method for detecting bacteria associated with parodontitis and tooth decay
05/15/2003CA2465731A1 Screening for hepatitis c virus entry inhibitors
05/15/2003CA2465724A1 Engineering of leader peptides for the secretion of recombinant proteins in bacteria
05/15/2003CA2465476A1 Methods and compositions for correction of cardiac conduction disturbances
05/15/2003CA2465361A1 Treatment of human cancer with adenoviral vector expressing tnf-.alpha.
05/15/2003CA2465239A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/15/2003CA2464977A1 Modulating urea degradation in wine yeast
05/15/2003CA2464766A1 Detection of predisposition to osteoporosis
05/15/2003CA2464765A1 Type 2 cytokine receptor and nucleic acids encoding same
05/15/2003CA2464626A1 Method for the in vitro synthesis of short double stranded rnas
05/15/2003CA2464615A1 Pharmaceutical composition comprising factor vii polypeptides and factor v polypeptides
05/15/2003CA2464470A1 Novel epidermal growth factor protein and gene, and methods of use therefor
05/15/2003CA2463855A1 Weed controller metabolism proteins, genes thereof and use of the same
05/15/2003CA2463705A1 Method of selecting hla-dp4 ligands and the applications thereof
05/15/2003CA2462462A1 Peptides acting as both glp-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
05/15/2003CA2455878A1 Production of l-lysine by genetically modified corynebacterium glutamicum strains
05/14/2003EP1310800A2 Functional assay for agonist activation of neuroreceptors
05/14/2003EP1310799A1 In vitro screening for ligands of the estrogen receptor
05/14/2003EP1310798A2 Cell tests and diagnostic index for Alzheimer's disease
05/14/2003EP1310795A1 Chemical sensor and method of detecting chemical
05/14/2003EP1310571A2 A Method of detecting and/or identifying adeno-associated virus (AVV) sequences and isolating novel sequences identified thereby
05/14/2003EP1310569A2 Method and test kit for the detection of genes
05/14/2003EP1310564A1 General means of labeling protein by using wheat embryo cell-free protein synthesis system
05/14/2003EP1310561A1 Chimeric promoters for controlling expression in skeletal muscle cells
05/14/2003EP1310560A1 Method of modifying microorganism-origin transglutaminase
05/14/2003EP1310559A1 Process for the production of alpha interferon of therapeutical degree
05/14/2003EP1310558A2 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
05/14/2003EP1310557A1 Design of bioactive peptides based on immunoglobulin structure
05/14/2003EP1310555A2 Oligonucleotide modulation of protein kinase C
05/14/2003EP1310552A2 Posh nucleic acids, polypeptides and related methods
05/14/2003EP1310551A1 Virus-like micrograins and process for producing the same
1 ... 2519 2520 2521 2522 2523 2524 2525 2526 2527 2528 2529 2530 2531 2532 2533 2534 2535 2536 2537 2538 2539 ... 4023